This disease complexity presents a challenge in the treatment of epilepsy, where available anti-seizure medications (ASMs) that are tailored to the epilepsy syndrome generally only achieve a 3050% responder rate (Lscher and Klein, 2021)
1987 Nov 15
Demers, A., McNicoll, N., Febbraio, M., Servant, M., Marleau, S., Silverstein, R., & Ong, H
Promotion of osteochondral repair through immune microenvironment regulation and activation of endogenous chondrogenesis via the release of apoptotic vesicles from donor MSCs
Patients whose primary complaint is physical performance and recovery rather than energy or cognition
Buzz'in Orange flavor: A delicious and refreshing way to elevate your daily routine